Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $345.31 million. The enterprise value is $154.32 million.
| Market Cap | 345.31M |
| Enterprise Value | 154.32M |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 80.30 million shares outstanding. The number of shares has decreased by -4.44% in one year.
| Current Share Class | 80.30M |
| Shares Outstanding | 80.30M |
| Shares Change (YoY) | -4.44% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 16.08% |
| Owned by Institutions (%) | 68.06% |
| Float | 60.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.97 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.00, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.00 |
| Quick Ratio | 7.64 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.24% and return on invested capital (ROIC) is -43.59%.
| Return on Equity (ROE) | -63.24% |
| Return on Assets (ROA) | -39.51% |
| Return on Invested Capital (ROIC) | -43.59% |
| Return on Capital Employed (ROCE) | -97.81% |
| Weighted Average Cost of Capital (WACC) | 8.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.83M |
| Employee Count | 55 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.86% in the last 52 weeks. The beta is 0.72, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +22.86% |
| 50-Day Moving Average | 4.79 |
| 200-Day Moving Average | 4.95 |
| Relative Strength Index (RSI) | 45.55 |
| Average Volume (20 Days) | 303,421 |
Short Selling Information
The latest short interest is 3.01 million, so 3.75% of the outstanding shares have been sold short.
| Short Interest | 3.01M |
| Short Previous Month | 3.07M |
| Short % of Shares Out | 3.75% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 10.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | -143.97M |
| Operating Income | -171.83M |
| Pretax Income | -162.06M |
| Net Income | -155.40M |
| EBITDA | -171.42M |
| EBIT | -171.83M |
| Earnings Per Share (EPS) | -$1.96 |
Balance Sheet
The company has $191.20 million in cash and $213,000 in debt, with a net cash position of $190.99 million or $2.38 per share.
| Cash & Cash Equivalents | 191.20M |
| Total Debt | 213,000 |
| Net Cash | 190.99M |
| Net Cash Per Share | $2.38 |
| Equity (Book Value) | 175.68M |
| Book Value Per Share | 2.19 |
| Working Capital | 175.24M |
Cash Flow
| Operating Cash Flow | -140.57M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 416,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -140.57M |
| FCF Per Share | -$1.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.44% |
| Shareholder Yield | 4.44% |
| Earnings Yield | -45.52% |
| FCF Yield | -40.71% |
Analyst Forecast
The average price target for AVIR is $9.00, which is 109.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.00 |
| Price Target Difference | 109.30% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |